Is that glass half-empty, or half-full? Be careful – your answer may result in telomere shortening!

We all know people, be they friends, family or colleagues, who seem to have a permanently downbeat view of life. Worryingly for them, research over the last few years has indicated that a negative outlook for the future has been associated with both faster progression of age-related disease, and earlier mortality. Furthermore, telomere attrition occurs with age, and being at the wrong end of the telomere length distribution at any given age is associated with increased risk of a number of diseases, including cardiovascular disease.

So it should come as no surprise to learn that chronic psychological stress has been associated with accelerated telomere shortening in circulating white blood cells. The problem arises in trying to provide a biological mechanism that links this form of stress to increased telomere loss. To address this, a group including the telomere/stress heavyweights Epel and Blackburn noted that both acute and chronic stress have been associated with increased interleukin-6 (an inflammatory cytokine), and repeated bouts of inflammation are associated with telomere shortening. Thus the authors set out to link stress (in this study the measure was optimism vs. pessimism) to telomere shortening via IL-6 in a cohort of post-menopausal women:

Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women.

The combination of less positive and more negative expectations for the future (i.e., lower optimism and higher pessimism) increases risk for disease and early mortality. We tested the possibility that expectancies might influence health outcomes by altering the rate of biological aging, specifically of the immune system (immunosenescence). However, no studies to date have examined associations between optimism or pessimism and indicators of immunosenescence such as leukocyte telomere length (TL) and interleukin-6 (IL-6) levels. We investigated whether dispositional tendencies towards optimism and pessimism were associated with TL and IL-6 in a sample of 36 healthy post-menopausal women. Multiple regression analyses where optimism and pessimism were entered simultaneously, and chronological age and caregiver status was controlled, indicated that pessimism was independently associated with shorter TL (beta=-.68, p=.001) and higher IL-6 concentrations (beta=.50, p=.02). In contrast, optimism was not independently associated with either measure of immunosenescence. These findings suggest that dispositional pessimism may increase IL-6 and accelerate rate of telomere shortening. Mechanistic causal relationships between these parameters need to be investigated.

As with the previous Epel/Blackburn paper (showing that “intrusive thoughts” impact on telomere length), the psychological measures (optimism, pessimism and perceived stress) were all based on questionnaires. As a molecular biologist who is accustomed to running standardized assays I will always have a little trouble when the data comes from a subject assigning a score to a comment such as, “If something can go wrong for me, it will”. I worry that there is such a subjective element to this type of study, but appreciate that in psychology there is little alternative.

This relatively small study of 36 post-menopausal women comprised 81% white subjects. Given the recent observations that ethnicity impacts on telomere length, it would have been sensible to include subjects from a single ethnic group to reduce the number of confounding variables. (There is no mention of any impact of ethnicity on telomere length, or if it was even considered as a confounder.)

There is also evidence that telomere attrition rates may differ in pre- vs. post-menopausal woman, a phenomenon that may be related to telomerase stimulation by estrogen. Therefore, it is pleasing to see that all subjects were post-menopausal (the authors have previously correlated perceived stress in post-menopausal women with shorter telomeres, but stress that this study is a different cohort).

The study reported a significant, negative association between IL-6 and telomere length, although the authors clearly state that this is not proof of causality: it may be that it is the critical shortening of telomeres that triggers inflammation rather that the other way around. Of the psychological measures optimism was not associated with either telomere length or IL-6, while pessimism is associated with both. This observation feels slightly counter-intuitive; is reduced pessimism not the same as increased optimism? If so, one would expect that if pessimism associates with shorter telomeres then surely optimism would associate with longer telomeres? Clearly this is not the case. As in the previous Epel/Blackburn study, higher levels of perceived stress were also associated with shorter telomeres, leading to the conclusion that “exposure to psychological stressors in pessimists could contribute to to chronic low-level increases in circulating pro-inflammatory cytokines…contributing to telomere shortening”. While this was a small study, it does add weight to the hypothesis that an individual’s psychological disposition is a contributing factor to poor health outcomes.

Cause for further concern for our downbeat friends is that an individual’s score on optimism and pessimism measures generally remain stable across time (important to note that this was not assessed in the present study, but has been replicated in earlier studies). Unfortunately for the happy folk out there, optimism again fails to associate with “better” health outcomes — so we may as well all take the middle-ground on this one.

Advertisements

17 comments

  1. Jim,

    The last comment was intended as tongue-in-cheek, so of course I agree with you on that one! Also, there a probably many other postive outcomes that DO associate with optimism…

  2. We’ll all die at some point, but your “odds ratio” for dying (of CV disease) is much higher if you are towards the telomere length distribution for your age.

  3. That should read: “towards the bottom end of the telomere length distribution for your age”.

  4. Speaking of self-fulfilling prophecies, ultimately the pessimism is justified. Or is it that the other way around–could it be that the pessimism is simply part and parcel of the same genetic structure that creates the higher degree of aging?

  5. I think there may actually be an answer.

    If you are filling the glass, then it will be half full,

    If you are emptying the glass, then it will be half empty.

    😀

  6. I have finally come up with the inarguable answer to “is the glass half empty or half full, but what if it’s just sitting there?” question.

    If you are filling the glass, it’s half full. If you’re emptying it, it’s half empty. If it’s just sitting there, it’s sitting at half capacity!!!

  7. hi there
    i like the website as i am interested in the science and use to be a research agronomist.
    i found the following interesting an on topic
    Mannoheptulose: glycolytic inhibitor and novel caloric restriction mimetic George Roth1, Mike Hayek2, Stefan Massimino2, Gary Davenport2, Robert Arking3, Andrzej Bartke4, Michael Bonkowski4 and Don Ingram5
    Caloric restriction (CR) is the most robust and reproducible strategy for retarding aging. Benefits of CR have been demonstrated in multiple species, but application to human or companion animal aging represents a challenge. In 1998 the concept of CR “mimetic” (CRM) was introduced as a method to obtain “anti-aging” and health-promoting benefits of CR without reducing food intake. We hypothesized that an effective CRM would best mimic the effects of CR if it impeded initial stages of energy metabolism. We focused initially on glycolytic inhibition using 2-deoxyglucose (2DG). Upon entry into cells, this glucose analog is phosphorylated and becomes a strong competitive inhibitor of phosphohexose isomerase. 2DG effectively induces a CR-like state in rats based on metabolic effects such as reduced plasma glucose, insulin, body temperature, pulse, heart rate and inhibiting tumor growth. Results show 2DG has a narrow window between efficacy and toxicity so recently we shifted our focus to mannoheptulose (MH), a seven-carbon sugar that reduces glycolysis via hexokinase inhibition. MH appears non-toxic with negligible effects on food intake and BW, and increased insulin tolerance by 25% in mice. MH extends median and maximal lifespan (~15%) in D. melanogaster and median lifespan (~30%) in C3H/HeJ mice. These findings, coupled with simple extraction from avocados, suggest that MH may be a practical, highly effective CRM.

    the amount of avocado which needs to be taken as far as i can calculate is about one large avocado a day

  8. I think it depends if it was poured or drank. If you pour it its half full. If you drank it its half empty.

Comments are closed.